Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Estradiol enhances osteolytic lesions in mice inoculated with human estrogen receptor-negative MDA-231 breast cancer cells in vivo.

Winding B, Misander H, Høegh-Andersen P, Brünner N, Foged NT.

Breast Cancer Res Treat. 2003 Mar;78(2):205-16.

PMID:
12725420
2.

Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice.

Winding B, NicAmhlaoibh R, Misander H, Høegh-Andersen P, Andersen TL, Holst-Hansen C, Heegaard AM, Foged NT, Brünner N, Delaissé JM.

Clin Cancer Res. 2002 Jun;8(6):1932-9.

3.

Human breast cancer cells induced angiogenesis, recruitment, and activation of osteoclasts in osteolytic metastasis.

Winding B, Misander H, Sveigaard C, Therkildsen B, Jakobsen M, Overgaard T, Oursler MJ, Foged NT.

J Cancer Res Clin Oncol. 2000 Nov;126(11):631-40.

PMID:
11079727

Supplemental Content

Loading ...
Support Center